121 related articles for article (PubMed ID: 16800969)
1. PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2.
Albain KS; Belani CP; Bonomi P; O'Byrne KJ; Schiller JH; Socinski M
Clin Lung Cancer; 2006 May; 7(6):417-9. PubMed ID: 16800969
[No Abstract] [Full Text] [Related]
2. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
Langer CJ; O'Byrne KJ; Socinski MA; Mikhailov SM; Leśniewski-Kmak K; Smakal M; Ciuleanu TE; Orlov SV; Dediu M; Heigener D; Eisenfeld AJ; Sandalic L; Oldham FB; Singer JW; Ross HJ
J Thorac Oncol; 2008 Jun; 3(6):623-30. PubMed ID: 18520802
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel poliglumex/carboplatin is similar to paclitaxel/carboplatin as first-line treatment in elderly patients with advanced non-small-cell lung cancer and a poor performance status.
Reddy GK
Clin Lung Cancer; 2005 Jul; 7(1):20-2. PubMed ID: 16098240
[No Abstract] [Full Text] [Related]
4. Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.
Paz-Ares L; Ross H; O'Brien M; Riviere A; Gatzemeier U; Von Pawel J; Kaukel E; Freitag L; Digel W; Bischoff H; García-Campelo R; Iannotti N; Reiterer P; Bover I; Prendiville J; Eisenfeld AJ; Oldham FB; Bandstra B; Singer JW; Bonomi P
Br J Cancer; 2008 May; 98(10):1608-13. PubMed ID: 18475293
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical trial of XYOTAX in non-small cell lung cancer to continue.
Expert Rev Anticancer Ther; 2002 Jun; 2(3):244-5. PubMed ID: 12113042
[No Abstract] [Full Text] [Related]
6. CT-2103 extends median survival of high-risk lung cancer patients.
Oncology (Williston Park); 2003 Dec; 17(12):1804, 1809. PubMed ID: 14723015
[No Abstract] [Full Text] [Related]
7. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A
Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
[TBL] [Abstract][Full Text] [Related]
8. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of paclitaxel poliglumex as first-line chemotherapy in patients at high risk with advanced-stage non-small-cell lung cancer: results of a phase II study.
Richards DA; Richards P; Bodkin D; Neubauer MA; Oldham F
Clin Lung Cancer; 2005 Nov; 7(3):215-20. PubMed ID: 16354318
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
13. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer may be different for men and women, but researchers ponder what to do?
Hede K
J Natl Cancer Inst; 2007 Dec; 99(24):1830-2. PubMed ID: 18073369
[No Abstract] [Full Text] [Related]
15. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
O'Brien ME; Socinski MA; Popovich AY; Bondarenko IN; Tomova A; Bilynsky BT; Hotko YS; Ganul VL; Kostinsky IY; Eisenfeld AJ; Sandalic L; Oldham FB; Bandstra B; Sandler AB; Singer JW
J Thorac Oncol; 2008 Jul; 3(7):728-34. PubMed ID: 18594318
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study.
Natale RB
Semin Oncol; 1995 Dec; 22(6 Suppl 15):34-7. PubMed ID: 8643968
[TBL] [Abstract][Full Text] [Related]
18. Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.
Edelman MJ
Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S30-4. PubMed ID: 19362944
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
